Skip to main content
    G

    Galecto Inc (GLTO)

    Official site

    BIOTECHNOLOGY

    $21.60
    -0.45 (-2.04%)

    Last updated: Nov 13, 2026 at 4:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    82%(14/17)
    Avg Surprise
    +12.55%
    Last 12 of 22 reported quarters
    PeriodReportedEst.RangeSurpriseB/MAnalystsRevisionsYoY
    Sep 25
    Reported Nov 6
    -$2.36N/AN/A----+30.4%
    Jun 25
    Reported Aug 11
    -$2.60N/AN/A--0
    No revisions (30d)
    -1525.0%
    Mar 25
    Reported Apr 28
    -$1.92N/AN/A--0
    No revisions (30d)
    -858.0%
    Dec 24
    Reported Mar 19
    -$5.00-$2.82N/A-77.31%Miss---1983.3%
    Sep 24
    Reported Nov 1
    -$3.39-$3.70-$4.50 - -$3.70+8.38%Beat2
    1
    0
    30d
    -1030.0%
    Jun 24
    Reported Aug 5
    -$0.16-$0.31-$0.39 - -$0.24+48.39%Beat2
    No revisions (30d)
    +61.0%
    Mar 24
    Reported Apr 29
    -$0.20-$0.41-$0.41 - -$0.41+51.22%Beat1
    No revisions (30d)
    +60.8%
    Dec 23
    Reported Mar 8
    -$0.24-$0.31N/A+22.58%Beat--+56.4%
    Sep 23
    Reported Nov 6
    -$0.30-$0.47-$0.59 - -$0.38+36.17%Beat3
    No revisions (30d)
    +44.4%
    Jun 23
    Reported Jul 31
    -$0.41-$0.59-$0.61 - -$0.56+30.51%Beat3
    No revisions (30d)
    +38.8%
    Mar 23
    Reported Apr 28
    -$0.51-$0.62-$0.69 - -$0.56+17.74%Beat2
    No revisions (30d)
    +23.9%
    Dec 22
    Reported Mar 9
    -$0.55-$0.57N/A+3.51%Beat---3.8%

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCF-2.34xFCF Yield-42.66%
    Profitability
    Profit MarginN/AOperating MarginN/A
    ROEN/AROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio3.73xQuick Ratio3.73x
    Trading Statistics
    BetaN/AAvg Volume492.54K
    52-Week HighN/A52-Week LowN/A

    Technical Indicators Dashboard

    As of Nov 16, 2026, the price is 2.7% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 46.8, in the neutral range between 30 and 70.

    Moving Averages

    SMA 10$22.73
    SMA 20$22.00
    SMA 50$22.19
    SMA 200$25.49
    EMA 10$22.51
    EMA 20$22.17
    EMA 50$22.83
    EMA 200$23.22

    MACD

    Line: 0.28Signal: 0.16Hist: 0.11

    ADX

    ADX: 19.1+DI: 19.2-DI: 17.9

    Aroon & PSAR

    Aroon Up92.0
    Aroon Down20.0
    PSAR$25.07

    Bollinger Bands

    Upper Band$24.33
    Lower Band$19.66
    %B Position2124%(Upper)
    Band Width0.42

    RSI (14-Day)

    Neutral
    46.8

    Momentum Oscillators

    Stoch %K42.8
    Stoch %D59.9
    Williams %R-71.7
    ROC (10d)0.5%
    Momentum0.11
    CCI (20d)-21.7
    MFI (14d)53.2

    Volatility Measures

    ATR (14d)$1.72(8.0%)
    StdDev (20d)1.17
    Hist Vol59.6%(High)

    Volume Flow

    VWAP$21.70
    OBV212.3M
    AD Line-106.2M
    CMF (20d)-0.082

    Volume Metrics

    Avg Vol (20d)482.1K
    Vol Ratio1.0x
    VWMA (20d)$22.11

    Pivot Points

    R3$24.01
    R2$23.53
    R1$22.79
    Pivot Point$22.31
    S1$21.57
    S2$21.09
    S3$20.35

    Advanced Oscillators

    TSI6.10
    Ultimate Osc43.7
    KST92.54

    Financial Performance

    Related GNG Research

    No research available

    Be the first to write about GLTO

    News

    No news available

    Company news will appear here when available

    GLTO Valuation

    P/FCF
    -2.3x
    P/B
    4.3x
    All GLTO metrics

    GLTO Profitability: Margins, ROIC and FCF

    Galecto Competitors

    Peers by sector and size for Galecto (GLTO) include Sangamo Therapeutics, Evoke Pharma and Pelthos Therapeutics.

    Sector: Healthcare

    GLTO Bull Case vs Bear Case

    Bull case

    • GLTO beat EPS estimates in 87.5% of its last 8 reported quarters.

    GLTO Earnings: Beat Rate

    Beat rate
    7 of 8 quarters (87.5%)
    Average surprise
    17.2%

    Updated Nov 20, 2025. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.